CIAM
VRDN icon

Caitong International Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Caitong International Asset Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.27M Buy
64,980
+64,976
+1,624,400% +$1.93M 0.24% 94
2025
Q4 		$124 Buy
+4
New +$110 ﹤0.01% 1677
2025
Q3 		– Sell
-173
Closed -$2.42K – 2559
2025
Q2 		$2.42K Buy
173
+4
+2% +$54 ﹤0.01% 1322
2025
Q1 		$2.28K Sell
169
-4,269
-96% -$72.7K ﹤0.01% 1287
2024
Q4 		$85.1K Buy
+4,438
New +$96.5K 0.08% 282

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return